| scholarly article | Q13442814 |
| P50 | author | Pier Paolo Pandolfi | Q7191735 |
| Laura Poliseno | Q42850198 | ||
| Andrea Marranci | Q86746449 | ||
| P2093 | author name string | Andrea Marranci | |
| P2860 | cites work | The landscape of long noncoding RNAs in the human transcriptome | Q22122065 |
| A coding-independent function of gene and pseudogene mRNAs regulates tumour biology | Q24632651 | ||
| Competing endogenous RNA networks: tying the essential knots for cancer biology and therapeutics | Q28088356 | ||
| HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs | Q28652432 | ||
| Characterization of human pseudogene-derived non-coding RNAs for functional potential | Q28660423 | ||
| Expressed pseudogenes in the transcriptional landscape of human cancers | Q28703606 | ||
| Transcribed pseudogene ψPPM1K generates endogenous siRNA to suppress oncogenic cell growth in hepatocellular carcinoma | Q28709356 | ||
| Landscape of transcription in human cells | Q29547467 | ||
| A draft map of the human proteome | Q29617250 | ||
| A genetic variant in pseudogene E2F3P1 contributes to prognosis of hepatocellular carcinoma | Q33858532 | ||
| Computational analysis identifies a sponge interaction network between long non-coding RNAs and messenger RNAs in human breast cancer. | Q33962806 | ||
| Clinical significance of POU5F1P1 rs10505477 polymorphism in Chinese gastric cancer patients receving cisplatin-based chemotherapy after surgical resection | Q34072513 | ||
| There is a world beyond protein mutations: the role of non-coding RNAs in melanomagenesis | Q40150714 | ||
| Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA PTENP1 and MicroRNA regulation | Q41533514 | ||
| microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer | Q41830068 | ||
| Deletion of PTENP1 pseudogene in human melanoma | Q42965863 | ||
| Methods to detect transcribed pseudogenes: RNA-Seq discovery allows learning through features. | Q45929791 | ||
| Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association. | Q54245305 | ||
| Identification of BRAF 3'UTR Isoforms in Melanoma. | Q54290095 | ||
| Significant correlation between the breakpoints of rare clonal aberrations in benign solid tumors and the assignment of HMGIY retropseudogenes | Q74840970 | ||
| Pseudogene: promising signature for cancer reclassification : comment on "The Pan-Cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypes", Nat Commun. 2014; 5:3963 | Q86068877 | ||
| All the Tested Human Somatic Cells Express Both Oct4A and Its Pseudogenes but Express Oct4A at Much Lower Levels Compared with Its Pseudogenes and Human Embryonic Stem Cells | Q86749180 | ||
| The OCT4 pseudogene POU5F1B is amplified and promotes an aggressive phenotype in gastric cancer | Q86992525 | ||
| Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin | Q34123261 | ||
| The emerging role of pseudogene expressed non-coding RNAs in cellular functions | Q34160931 | ||
| The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion | Q34184031 | ||
| A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells | Q34329463 | ||
| Pseudogene in cancer: real functions and promising signature | Q34447589 | ||
| The 3'UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1. | Q34463863 | ||
| The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo. | Q34470339 | ||
| Pseudogene PTENP1 Suppresses Gastric Cancer Progression by Modulating PTEN. | Q34476135 | ||
| CRISPR/Cas9-mediated gene knockout of NANOG and NANOGP8 decreases the malignant potential of prostate cancer cells | Q34481297 | ||
| Expression profile of COL2A1 and the pseudogene SLC6A10P predicts tumor recurrence in high-grade serous ovarian cancer | Q34491120 | ||
| Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression | Q34693185 | ||
| Pseudogene-derived lncRNAs: emerging regulators of gene expression | Q35048014 | ||
| Expression and differentiation between OCT4A and its Pseudogenes in human ESCs and differentiated adult somatic cells | Q35107589 | ||
| The Pan-Cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypes | Q35117286 | ||
| Pseudogenes transcribed in breast invasive carcinoma show subtype-specific expression and ceRNA potential | Q35131975 | ||
| Contribution of pseudogenes to sequence diversity | Q35167809 | ||
| A pseudogene-signature in glioma predicts survival | Q35191597 | ||
| Pseudogene INTS6P1 regulates its cognate gene INTS6 through competitive binding of miR-17-5p in hepatocellular carcinoma | Q35742379 | ||
| Epigenetic silencing of Oct4 by a complex containing SUV39H1 and Oct4 pseudogene lncRNA. | Q35877700 | ||
| Pseudogenes in metazoa: origin and features | Q35881978 | ||
| Evidence for conserved post-transcriptional roles of unitary pseudogenes and for frequent bifunctionality of mRNAs | Q36633078 | ||
| Role of the ERas gene in gastric cancer cells | Q37059411 | ||
| The pseudogene TUSC2P promotes TUSC2 function by binding multiple microRNAs | Q37497280 | ||
| Phosphatase and tensin homolog (PTEN) pseudogene expression in endometrial cancer: a conserved regulatory mechanism important in tumorigenesis? | Q37638254 | ||
| Processed pseudogenes acquired somatically during cancer development | Q37718241 | ||
| Pseudogenes: newly discovered players in human cancer | Q38044588 | ||
| ETS fusion genes in prostate cancer. | Q38198581 | ||
| Competing endogenous RNA interplay in cancer: mechanism, methodology, and perspectives | Q38325485 | ||
| PTEN ceRNA networks in human cancer. | Q38341492 | ||
| Pseudogene integrator complex subunit 6 pseudogene 1 (INTS6P1) as a novel plasma-based biomarker for hepatocellular carcinoma screening | Q38842696 | ||
| HMGA1-pseudogene expression is induced in human pituitary tumors. | Q38884465 | ||
| OCT4 pseudogene 5 upregulates OCT4 expression to promote proliferation by competing with miR-145 in endometrial carcinoma. | Q38915222 | ||
| Circulating CUDR, LSINCT-5 and PTENP1 long noncoding RNAs in sera distinguish patients with gastric cancer from healthy controls | Q39037474 | ||
| Pseudogene OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4 expression by competing for miR-145 in hepatocellular carcinoma | Q39161179 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 68 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Frontiers in Medicine | Q27726181 |
| P1476 | title | Pseudogenes in Human Cancer | |
| P478 | volume | 2 |
| Q45949988 | A novel computational method for inferring competing endogenous interactions. |
| Q58113118 | DUXAP8, a pseudogene derived lncRNA, promotes growth of pancreatic carcinoma cells by epigenetically silencing CDKN1A and KLF2 |
| Q92701884 | Deep Sequencing Analysis Reveals Distinctive Non-Coding RNAs When Comparing Tumor Multidrug-Resistant Cells and Extracellular Vesicles with Drug-Sensitive Counterparts |
| Q92959649 | Deregulation of H19 is associated with cervical carcinoma |
| Q47103159 | Ensemble Modeling Approach Targeting Heterogeneous RNA-Seq data: Application to Melanoma Pseudogenes |
| Q28072498 | HMGA1-pseudogenes and cancer |
| Q92102896 | Integrative analyses of noncoding RNAs reveal the potential mechanisms augmenting tumor malignancy in lung adenocarcinoma |
| Q92605008 | LncRNA PCNAP1 modulates hepatitis B virus replication and enhances tumor growth of liver cancer |
| Q46245433 | Network analysis of pseudogene-gene relationships: from pseudogene evolution to their functional potentials |
| Q58572038 | New insights into long noncoding RNAs and pseudogenes in prognosis of renal cell carcinoma |
| Q50601740 | Noise-induced multistability in the regulation of cancer by genes and pseudogenes. |
| Q52558382 | Noncoding RNA:RNA Regulatory Networks in Cancer. |
| Q99237897 | Overexpressed Pseudogene HLA-DPB2 Promotes Tumor Immune Infiltrates by Regulating HLA-DPB1 and Indicates a Better Prognosis in Breast Cancer |
| Q33613535 | Protein-Coding Genes' Retrocopies and Their Functions. |
| Q37734530 | Protein-coding genes in B chromosomes of the grasshopper Eyprepocnemis plorans |
| Q64085616 | PseudoFuN: Deriving functional potentials of pseudogenes from integrative relationships with genes and microRNAs across 32 cancers |
| Q37565147 | Pseudogene BMI1P1 expression as a novel predictor for acute myeloid leukemia development and prognosis |
| Q26738904 | Pseudogenes regulate parental gene expression via ceRNA network |
| Q37343623 | Putative RNA-Directed Adaptive Mutations in Cancer Evolution |
| Q89638490 | Re-recognition of pseudogenes: From molecular to clinical applications |
| Q58711458 | Reduced PRC2 function alters male germline epigenetic programming and paternal inheritance |
| Q58805123 | Role of Pseudogenes in Tumorigenesis |
| Q52729619 | The Unforeseen Non-Coding RNAs in Head and Neck Cancer. |
| Q41260767 | The pseudogene derived from long non-coding RNA DUXAP10 promotes colorectal cancer cell growth through epigenetically silencing of p21 and PTEN. |
| Q39149402 | The sex locus is tightly linked to factors conferring sex-specific lethal effects in the mosquito Aedes aegypti |
| Q47108376 | Transcription of a B chromosome CAP-G pseudogene does not influence normal Condensin Complex genes in a grasshopper |
| Q47098477 | dreamBase: DNA modification, RNA regulation and protein binding of expressed pseudogenes in human health and disease |
Search more.